Related Experiment Video
Updated: Dec 16, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes and COVID-19: Global and regional perspectives
In-Kyung Jeong1, Kun Ho Yoon2, Moon Kyu Lee3
1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
Insights
Diabetes significantly increases the risk of severe outcomes and death from coronavirus disease-2019 (COVID-19). Patients with diabetes require specific precautions and careful management during the COVID-19 pandemic.
Area of Science:
- Infectious Diseases
- Endocrinology
- Public Health
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in a global health crisis.
- Diabetes is identified as a major risk factor for severe COVID-19 outcomes.
- Diabetic patients face increased vulnerability due to hyperglycemia, impaired immunity, and comorbidities.
Purpose of the Study:
- To review current knowledge on COVID-19 epidemiology and virology.
- To examine the impact of diabetes on COVID-19 severity and mortality.
- To discuss COVID-19 treatment and diabetes management standards during the pandemic.
Main Methods:
- Literature review of COVID-19 and diabetes research.
- Analysis of epidemiological data and clinical outcomes.
- Synthesis of information on treatment strategies and care standards.
Main Results:
- COVID-19 severity and mortality rates are significantly higher in diabetic patients.
- Hyperglycemia, immune dysfunction, and comorbidities exacerbate COVID-19 in diabetics.
- ACE2 receptor interaction highlights the need for caution with angiotensin-directed medications.
Conclusions:
- Diabetic patients are at high risk for severe COVID-19 and require heightened precautions.
- Effective management of diabetes is crucial during the pandemic.
- Further research is needed on specific treatment and care protocols for diabetic COVID-19 patients.
Abstract:
The coronavirus disease-2019 (COVID-19) has been designated as a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since December 2019, when an outbreak of pneumonia cases emerged in Wuhan, China. The COVID-19 pandemic has led to a global health crisis, devastating the social, economic and political aspects of life. Many clinicians, health professionals, scientists, organizations, and governments have actively defeated COVID-19 and shared their experiences of the SARS-CoV2. Diabetes is one of the major risk factors for fatal outcomes from COVID-19. Patients with diabetes are vulnerable to infection because of hyperglycemia; impaired immune function; vascular complications; and comorbidities such as hypertension, dyslipidemia, and cardiovascular disease. In addition, angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV-2 in the human body. Hence, the use of angiotensin-directed medications in patients with diabetes requires attention. The severity and mortality from COVID-19 was significantly higher in patients with diabetes than in those without. Thus, the patients with diabetes should take precautions during the COVID-19 pandemic. Therefore, we review the current knowledge of COVID-19 including the global and regional epidemiology, virology, impact of diabetes on COVID-19, treatment of COVID-19, and standard of care in the management of diabetes during this critical period.
More Related Videos
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Psychoneuroimmunology: Diabetes and Cancer